Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9175261B2 · kind B2 · utility
2Cited by
92References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2006 |
| Grant date | Nov 3, 2015 |
| Priority date | — |
| Expiry date | Sep 15, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2035/122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cell-based compositions and methods of their use to inhibit an adverse immune response such as graft versus host disease or rejection of transplanted tissue in a transplant recipient that is histocompatibility mismatched to the transplant donor are disclosed. The compositions and methods utilize postpartum-derived cells, such as cells derived from the placenta or umbilicus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.